“Roche’s 2024 Results: A Strong Year of Growth with 7% Increase in Sales and Third Consecutive Quarter of 9% Growth – Ad Hoc Announcement under Art. 53 LR”
Group Sales Growth in Basel Basel, 30 January 2025 Group sales in Basel grew by 7% at constant exchange rates (CER; 3% in CHF), driven by strong demand for both medicines and diagnostics. Excluding COVID-19, Group sales increased by 9%. Impact on Individuals: For individuals, this increase in group sales could potentially lead to more…